Here, although melanoma (the tumor with the highest average TMB) presented with the greatest CD8+ TIL response, within melanoma a high TMB did not appear to represent a major driver for the accumulation of either tumor-reactive CD8+ TILs or CD4+ TILs. The gene discussed is CD8A; the disease is neoplasm.